We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Thor Industries
THO
$4.14B
| $350K | 0.05% |
+4,688
| New | +$364K |
|
727
Brookfield Renewable
BEPC
$6.26B
| $349K | 0.05% |
9,798
-3,710
| -27% | -$137K |
|
728
Clear Channel Outdoor Holdings
CCO
$1.23B
| $349K | 0.05% |
325,889
+256,384
| +369% | +$537K |
|
729
American Superconductor
AMSC
$1.59B
| $348K | 0.05% |
67,259
+28,443
| +73% | +$165K |
|
730
Oil States International
OIS
$491M
| $348K | 0.05% |
64,126
+46,670
| +267% | +$326K |
|
731
Wingstop
WING
$3.18B
| $348K | 0.05% |
+4,650
| New | +$405K |
|
732
Howard Hughes
HHH
$4.03B
| $347K | 0.05% |
+5,346
| New | +$439K |
|
733
Shoals Technologies Group
SHLS
$1.5B
| $347K | 0.05% |
+21,042
| New | +$311K |
|
|
HI
734
DELISTED
Hillenbrand
HI
| $346K | 0.05% |
+8,443
| New | +$353K |
|
735
Sarepta Therapeutics
SRPT
$1.77B
| $346K | 0.05% |
4,617
-1,215
| -21% | -$89.4K |
|
|
WCC
736
WESCO International
WCC
$17.7B
| $346K | 0.05% |
+3,233
| New | +$398K |
|
737
HNI Corp
HNI
$3.59B
| $345K | 0.05% |
+9,936
| New | +$361K |
|
738
Digi International
DGII
$3.1B
| $344K | 0.05% |
14,183
-5,245
| -27% | -$114K |
|
739
Rithm Capital
RITM
$5.69B
| $344K | 0.05% |
+36,959
| New | +$388K |
|
740
StoneX
SNEX
$7.94B
| $344K | 0.05% |
22,295
-13,355
| -37% | -$193K |
|
741
Travel + Leisure Co
TNL
$4.7B
| $344K | 0.05% |
+8,854
| New | +$437K |
|
742
Marriott International
MAR
$92.3B
| $343K | 0.05% |
2,521
-982
| -28% | -$162K |
|
|
AHT
743
Ashford Hospitality Trust
AHT
$21M
| $342K | 0.05% |
5,722
+2,305
| +67% | +$155K |
|
744
Caesars Entertainment
CZR
$6.14B
| $342K | 0.05% |
+8,917
| New | +$497K |
|
|
LTHM
745
DELISTED
Livent Corporation
LTHM
| $342K | 0.05% |
+15,075
| New | +$388K |
|
746
Lowe's Companies
LOW
$125B
| $340K | 0.05% |
+1,946
| New | +$375K |
|
747
Equifax
EFX
$21.4B
| $339K | 0.05% |
1,857
+753
| +68% | +$151K |
|
748
Matsons
MATX
$6.18B
| $339K | 0.05% |
+4,658
| New | +$400K |
|
|
HOUS
749
DELISTED
Anywhere Real Estate
HOUS
| $338K | 0.05% |
34,425
+10,277
| +43% | +$121K |
|
750
Laureate Education
LAUR
$5.28B
| $338K | 0.05% |
+29,217
| New | +$346K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.